Argonautica Private Wealth Management Inc. Has $268,000 Holdings in Chemed Co. (NYSE:CHE)

Argonautica Private Wealth Management Inc. grew its position in Chemed Co. (NYSE:CHE) by 7.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 505 shares of the company’s stock after buying an additional 34 shares during the quarter. Argonautica Private Wealth Management Inc.’s holdings in Chemed were worth $268,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. UMB Bank n.a. boosted its stake in Chemed by 300.0% in the 4th quarter. UMB Bank n.a. now owns 52 shares of the company’s stock worth $28,000 after purchasing an additional 39 shares during the period. Trust Co. of Vermont acquired a new stake in Chemed during the 4th quarter valued at $34,000. Allworth Financial LP boosted its position in shares of Chemed by 2,057.1% in the fourth quarter. Allworth Financial LP now owns 151 shares of the company’s stock worth $83,000 after buying an additional 144 shares during the period. Farther Finance Advisors LLC boosted its position in shares of Chemed by 2,314.3% in the third quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after buying an additional 324 shares during the period. Finally, KBC Group NV grew its holdings in shares of Chemed by 11.5% during the third quarter. KBC Group NV now owns 378 shares of the company’s stock valued at $227,000 after buying an additional 39 shares in the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently issued reports on CHE. StockNews.com raised Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, November 30th. Royal Bank of Canada reduced their price target on shares of Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research report on Tuesday, November 5th.

Insider Transactions at Chemed

In other Chemed news, VP Brian C. Judkins purchased 145 shares of the company’s stock in a transaction dated Monday, December 30th. The shares were bought at an average price of $519.50 per share, for a total transaction of $75,327.50. Following the purchase, the vice president now directly owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 3.32% of the company’s stock.

Chemed Trading Up 0.7 %

NYSE CHE opened at $551.28 on Wednesday. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $654.62. The firm’s fifty day simple moving average is $543.28 and its 200-day simple moving average is $563.22. The company has a market capitalization of $8.30 billion, a PE ratio of 27.86, a price-to-earnings-growth ratio of 2.15 and a beta of 0.48.

Chemed Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, March 14th. Shareholders of record on Monday, February 24th will be given a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.36%. The ex-dividend date is Monday, February 24th. Chemed’s payout ratio is currently 10.11%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.